Skip to content

A comparative study on the long-term weight control effect of balanced diet in obese children

A comparative study on the long-term weight control effect of balanced diet in obese children

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500097737
Enrollment
Unknown
Registered
2025-02-25
Start date
2024-07-10
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Interventions

Experimental group:Low GI dietary education
Control group:General dietary education

Sponsors

Children's Hospital, Zhejiang University School of Medicine, National Clinical Research
Lead Sponsor

Eligibility

Sex/Gender
All
Age
8 Years to 18 Years

Inclusion criteria

Inclusion criteria: Inclusion Criteria -1- Introduction of Intervention period (all items below must be met) (1) Children and adolescents aged 8-18 years who were clinically obese (2) The body mass index (BMI) was higher than the 95th percentile of the corresponding age level Inclusion criteria -2- Follow-up intervention period: Weight loss of at least 5% (BMI reduction >=5%) during the 21-day intervention

Exclusion criteria

Exclusion criteria: Exclusion criteria (excluded if any of the following items are met) (1) Children with T1D, severe abnormality of heart, lung, liver and kidney function (2) Children with low willingness to voluntarily cooperate with closed training camp management (3) Children with serious psychological disorders (anxiety, depression, bipolar disorder, etc.) (4) If there are children who are not suitable for short-term high-intensity intensive training outside the above exclusion indicators (such as musculoskeletal abnormalities, acute stage of infection, etc.) during the on-site physical examination, the expert group will discuss whether to exclude the case. (5) Excluded contents of other studies: use of weight-loss drugs, underwent weight-loss surgery, or changed the dose of drugs for lipid metabolism and hypertension within 3 months

Design outcomes

Primary

MeasureTime frame
Weight loss rebound rate;

Secondary

MeasureTime frame
Body mass index;Pancreas islet function;Lipid profile;Urine metabolite;Intestinal flora;

Countries

China

Contacts

Public ContactJunfen Fu

The Children's Hospital, Zhejiang University School of Medicine

fjf68@qq.com+86 137 7745 7849

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026